Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 89 results for "yeda research development company"

US patent office rules in favour of Mylan: Natco Pharma
Livemint.com

Natco Pharma moves up on the bourses

SENSEX 28467.24 43.76 0.15% NIFTY 8781.35 6.70 0.08% Industry: Medical/Healthcare Company Natco Pharma Ltd Natco Pharma is currently trading at Rs. 677.80, up by 0.90 points or 0.13% from its previous closing of Rs. 676.90 on ... Finalaya.com, 3 weeks ago
[x]  

426 images for yeda research development company

International Business Times, 1 week ago
Tech2 firstpost.com, 1 day ago
SourceSecurity.com, 2 days ago
TMC Net, 1 week ago
Yahoo! Singapore, 1 week ago
Financial Express, 4 days ago
Tech2, 1 day ago
Yahoo! Singapore, 2 weeks ago
WorldNetDaily, 2 weeks ago
Yahoo! Singapore, 2 weeks ago

Mylan wins round in fight with Teva over multiple sclerosis drug

WASHINGTON, Aug 24 (Reuters) - Pharmaceutical company Mylan NV has won a round in its fight with Teva Pharmaceutical Industries Ltd at the U.S. Patent and Trademark Office, which said on Wednesday that two patents for the multiple sclerosis drug ...
 Yahoo! Finance1 month ago UPDATE 2-Mylan wins round in fight with Teva over multiple sclerosis drug  Reuters UK1 month ago UPDATE 1-Mylan wins round in fight with Teva over multiple sclerosis drug  Reuters UK1 month ago
UCLA News

UCLA names Amir Naiberg associate vice chancellor for OIP-ISR

UCLA has named Amir Naiberg associate vice chancellor for the Office of Intellectual Property and Industry Sponsored Research ,and president and CEO of Westwood Technology Transfer. Naiberg, who joined UCLA August 3, leads the office thatoversees ...
 UCLA News1 month ago
Share Market Updates

HC Stocks in Hub! Exelixis, Inc. (EXEL), Mylan NV (NASDAQ:MYL)

Shares of Exelixis, Inc. (NASDAQ:EXEL) ended Friday session in green amid volatile trading. The shares closed up +0.15 points or 1.02 % at $ 14.89 with 5.49 million shares getting traded. Post opening the session at $ 14.74 , the shares hit an ...
 Share Market Updates3 days ago HC Stocks in Top Row! Mylan NV (MYL), Zoetis Inc (NYSE:ZTS)  Share Market Updates1 week ago HC Stocks Overview= Mylan NV (NASDAQ:MYL), St. Jude Medical, Inc. (STJ)  Share Market Updates2 weeks ago HC Stocks Indications= Mylan NV (MYL), Medtronic PLC (NYSE:MDT)  Share Market Updates2 weeks ago

Appointments, Resignations, Deaths (9/30/2016)

Central Piedmont Community College, Kandi Deitemeyer City University of Seattle, Randy Frisch Coastal Carolina Community College, David Heatherly Cooper Union for the Advancement of Science and Art, Laura Sparks Ivy Tech Community College ...
 Chronicle of Higher Education4 days ago

RBC Capital Markets Lowers Mylan Inc. (MYL) Price Target to $48.00

The stock has received "OVERWEIGHT" rating after consensus analysis from analysts. 13 number of analysts have estimated the sales of the company for the quarter ending Oct 28, 2016- Nov 1, 2016, analysts estimated mean sale target of 3289.14 ...
 Equilibrio Informativo3 weeks ago
Freshnews.com

AKORN : Generic Drugs Stocks Technical Reports -- Mylan, Horizon Pharma, Allergan, and Akorn

/PRNewswire/ -- Rising costs of brand-name medicines continue to drive more and more consumers to settle for the much cheaper Generic Drugs. This morning, Stock-Callers.com presents four stocks within the Generic Drugs space for review, one of which ...
 4 Traders3 weeks ago Generic Drugs Stocks Technical Reports -- Mylan, Horizon Pharma, Allergan, and Akorn  Asian Hospital & Healthcare Management3 weeks ago
[x]  
Bidness Etc

UPDATE 2-Third U.S. patent on Tevas MS drug Copaxone invalidated

(Adds comment from Teva, background) By Andrew Chung NEW YORK, Sept 1 Teva Pharmaceutical Industries on Thursday lost a third patent for its top-selling multiple sclerosis treatment as U.S. patent officials ruled that Copaxone did not ...
 Reuters UK4 weeks ago Teva Pharmaceutical Industries Ltd: PTAB Invalidates Two Patents; Copaxone Generics Unlikely in '17  Bidness Etc1 month ago Teva Plunges After Two U.S. Copaxone Patents Invalidated (3)  La Repubblica1 month ago
CNBC

Shares of Teva Pharmaceuticals fall after US Patent Office invalidates two patents

ewly-manufactured pills at Teva Pharmaceutical Industries headquarters in Jerusalem, Israel. Shares of Teva Pharmaceuticals fell as much as 6 percent on Wednesday after the U.S. Patent Office invalidated two of the company's patents. Mylan ...
 CNBC1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less